Answers are grounded in this paper and cite their sources.
Netrin 1 and members of the Slit family and their receptors are deregulated in a large proportion of human cancers, suggesting that they could be tumour suppressor genes or oncogenes. Evidence for and against these functions is discussed, along with recent data that these ligand–receptor pairs could be promising targets for personalized anticancer therapies. Over the past few years, several genes, proteins and signalling pathways that are required for embryogenesis have been shown to regulate tumour development and progression by playing a major part in overriding antitumour safeguard mechanisms. These include axon guidance cues, such as Netrins and Slits. Netrin 1 and members of the Slit family are secreted extracellular matrix proteins that bind to deleted in colorectal cancer (DCC) and UNC5 receptors, and roundabout receptors (Robos), respectively. Their expression is deregulated in a large proportion of human cancers, suggesting that they could be tumour suppressor genes or oncogenes. Moreover, recent data suggest that these ligand–receptor pairs could be promising targets for personalized anticancer therapies.
No takes yet. Share an insight, caveat, or question.
Mehlen et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: